Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Revenue: 2019-2024

Historic Revenue for Silence Therapeutics (SLN) over the last 6 years, with Dec 2024 value amounting to $43.3 million.

  • Silence Therapeutics' Revenue fell 89.39% to $159,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 25.38%. This contributed to the annual value of $43.3 million for FY2024, which is 36.71% up from last year.
  • Silence Therapeutics' Revenue amounted to $43.3 million in FY2024, which was up 36.71% from $31.6 million recorded in FY2023.
  • Silence Therapeutics' 5-year Revenue high stood at $43.3 million for FY2024, and its period low was $7.0 million during FY2020.
  • Its 3-year average for Revenue is $32.2 million, with a median of $31.6 million in 2023.
  • Data for Silence Therapeutics' Revenue shows a peak YoY skyrocketed of 2,158.34% (in 2020) over the last 5 years.
  • Over the past 5 years, Silence Therapeutics' Revenue (Yearly) stood at $7.0 million in 2020, then soared by 142.78% to $17.1 million in 2021, then rose by 26.77% to $21.7 million in 2022, then skyrocketed by 46.12% to $31.6 million in 2023, then skyrocketed by 36.71% to $43.3 million in 2024.